Evidence map›Paper›PMID 29080202›Full record

ReviewCurrent osteoporosis reports2017

Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment.

Sigrun R Hofmann, Franz Kapplusch, Hermann J Girschick, Henner Morbach, Jessica Pablik, Polly J Ferguson, Christian M Hedrich

Open access · hybridAbstract readReview
In one paragraph

Review in Current osteoporosis reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 137 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
137citing papers in PubMed, 4 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

137 citing papers in PubMed, 4 syntheses or guidelines pooled it, 288 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. A novelLife science alliance · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

77 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Sigrun R HofmannPediatric Rheumatology and Immunology, Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Franz KappluschPediatric Rheumatology and Immunology, Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Hermann J GirschickVivantes Klinikum Friedrichshain, Children's Hospital, Berlin, Germany.
Henner MorbachPediatric Rheumatology and Immunology, Children's Hospital, University of Würzburg, Würzburg, Germany.
Jessica PablikDivision of Pathology, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Polly J FergusonDepartment of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA, USA.
Christian M HedrichPediatric Rheumatology and Immunology, Department of Pediatrics, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Christian.hedrich@liverpool.ac.uk.
University Hospital Carl Gustav Carus · DEKlinikum im Friedrichshain · DETU Dresden · DEUniversitätsklinikum Würzburg · DEUniversity of Iowa Stead Family Children’s Hospital · USUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewChronic non-bacterial osteomyelitis (CNO) with its most severe form chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory bone disorder. We summarize the clinical presentation, diagnostic approaches, most recent advances in understanding the pathophysiology, and available treatment options and outcomes in CNO/CRMO. RECENT

findingsThough the exact molecular pathophysiology of CNO/CRMO remains somewhat elusive, it appears likely that variable defects in the TLR4/MAPK/inflammasome signaling cascade result in an imbalance between pro- and anti-inflammatory cytokine expressions in monocytes from CNO/CRMO patients. In this context, we present previously unpublished data on cytokine and chemokine expression in monocytes and tissues. CNO/CRMO is an autoinflammatory bone disorder resulting from imbalanced cytokine expression from innate immune cells. Though the exact molecular pathophysiology remains unclear, variable molecular defects appear to result in inflammasome activation and pro-inflammatory cytokine expression in monocytes from CNO/CRMO patients. Recent advances suggest signaling pathways and single molecules as biomarkers for CNO/CRMO as well as future treatment targets.

Indexed as

Adrenal Cortex HormonesAnimalsAnti-Inflammatory Agents, Non-SteroidalBone Density Conservation AgentsChemokine CCL2Chemokine CCL4Chemokine CCL5ChemokinesCytokinesDiphosphonatesDisease Models, AnimalHumansImmunosuppressive AgentsInflammasomesInterleukin-12Interleukin-6Adrenal Cortex HormonesAnti-Inflammatory Agents, Non-SteroidalBone Density Conservation AgentsChemokine CCL2Chemokine CCL4Chemokine CCL5ChemokinesCytokinesDiphosphonatesImmunosuppressive AgentsInflammasomesInterleukin-12Interleukin-6MethotrexateMitogen-Activated Protein KinasesReceptors, Interleukin-2SulfasalazineToll-Like Receptor 4Tumor Necrosis Factor-alphaBiomarkersBoneChronic non-bacterial osteomyelitisChronic recurrent multifocal osteomyelitisCNOCRMOCytokineInflammationTreatment

Identifiers

PMID29080202
PMCPMC5705736
OpenAlexW2765501886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.